OSTEOPOROSIS AFTER LONG-TERM CORTICOSTEROID TREATMENT OF GIANT-CELL ARTERITIS

被引:24
|
作者
ANDERSSON, R
RUNDGREN, A
ROSENGREN, K
BENGTSSON, BA
MALMVALL, BE
MELLSTROM, D
机构
[1] VASA HOSP, DEPT RADIOL, GOTHENBURG, SWEDEN
[2] GOTHENBURG UNIV, SAHLGRENS HOSP, DEPT INTERNAL MED 2, S-41345 GOTHENBURG, SWEDEN
[3] JONKOPING HOSP, DEPT INFECT DIS, JONKOPING, SWEDEN
关键词
corticosteroids; dual photon absoptiometry; GCA; osteoporosis; population study; side‐effects; X‐ray;
D O I
10.1111/j.1365-2796.1990.tb00177.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abstract. The mineral content of the heel bone, and signs of osteoporosis on X‐ray of the spine, were evaluated in 26 patients (20 women and 6 men) with giant cell arteritis (GCA), treated with prednisolone for an average period of 5 years. The mean age was 78 years (range 66–95 years). These results were compared with those obtained from a large population study of individuals aged 72, 75, 82 and 85 years. An increase of obvious and severe spinal osteoporosis from 16 to 85% was observed in the women in the population study between the ages of 72 and 85. No additional osteoporosis that could be attributed to the cortisone treatment was found among the GCA patients. The bone mineral content was not reduced in the patients compared to the general population. We conclude that there is no justification for attempting non‐steroid treatment in GCA on account of the risk of osteoporosis. Corticosteroids are the only safe treatment for prevention of complications of GCA. 1990 Blackwell Publishing Ltd
引用
收藏
页码:391 / 395
页数:5
相关论文
共 50 条
  • [1] LONG-TERM CORTICOSTEROID TREATMENT IN GIANT-CELL ARTERITIS
    ANDERSSON, R
    MALMVALL, BE
    BENGTSSON, BA
    ACTA MEDICA SCANDINAVICA, 1986, 220 (05): : 465 - 469
  • [2] METHOTREXATE TREATMENT IN GIANT-CELL ARTERITIS - LONG-TERM FOLLOW-UP
    JOVER, JA
    MORADO, G
    COLLADO, P
    RAMOS, P
    FERNANDEZ, B
    BANARES, A
    HERNANDEZ, C
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S141 - S141
  • [3] PREVENTION OF BLINDNESS IN GIANT-CELL ARTERITIS BY CORTICOSTEROID TREATMENT
    MYLES, AB
    PERERA, T
    RIDLEY, MG
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (02): : 103 - 105
  • [4] TREATMENT OF CORTICOSTEROID-RESISTANT GIANT-CELL ARTERITIS
    WILKE, WS
    HOFFMAN, GS
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1995, 21 (01) : 59 - 71
  • [5] PERSISTENT GIANT-CELL ARTERITIS DESPITE CORTICOSTEROID TREATMENT
    EVANS, JM
    BATTS, KP
    HUNDER, GG
    MAYO CLINIC PROCEEDINGS, 1994, 69 (11) : 1060 - 1061
  • [6] Corticosteroid Therapy in Giant Cell Arteritis, Predictors for Long-Term Remission
    Boiardi, Luigi
    Restuccia, Giovanna
    Macchioni, Pierluigi
    Muratore, Francesco
    Cavazza, Alberto
    Cimino, Luca
    Aldigeri, Raffaella
    Catanoso, Mariagazia
    Pipitone, Nicolo
    Salvarani, Carlo
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] LONG-TERM RESULTS OF TREATMENT OF GIANT-CELL TUMOR
    BARFOD, G
    LAUSTEN, G
    DAUGARD, S
    SCHIODT, T
    LUND, B
    ACTA ORTHOPAEDICA SCANDINAVICA, 1986, 57 (02): : 177 - 177
  • [8] LONG-TERM SURVIVAL OF PATIENTS WITH GIANT-CELL ARTERITIS FROM THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY GIANT-CELL ARTERITIS CLASSIFICATION CRITERIA COHORT
    MATTESON, EL
    GOLD, KN
    BLOCH, DA
    HUNDER, GG
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 633 - 633
  • [9] TREATMENT OF GIANT-CELL ARTERITIS
    WECHSLER, B
    CABANE, J
    GAZETTE MEDICALE, 1984, 91 (18): : 62 - 64
  • [10] TREATMENT OF GIANT-CELL ARTERITIS
    BARRIER, JH
    ANNALES DE MEDECINE INTERNE, 1994, 145 (08): : 533 - 537